Avaliação Económica de Fidaxomicina no Tratamento de Infeções por Clostridium Difficile Graves ou Recorrentes
Objectives: Fidaxomicin is a macrocyclic antibiotic drug indicated for the treatment of Clostridium difficile infections (CDI). The purpose of this study was to evaluate from a societal perspective the cost-effectiveness and cost-utility of fidaxomicin in the treatment of severe or recurrent CDI com...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Book |
| Published: |
Formifarma, LDA.,
2013-10-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|